Tirzepatide mg to units: what the numbers on your Mounjaro pen mean

All Mounjaro (tirzepatide) KwikPens share the same concentration: 4 mg per ml, so mg and ml figures are linked by a fixed ratio.
The pen's dose selector and plunger do the measuring for you — patients never need to convert tirzepatide mg to units to draw up a dose.
The six licensed UK strengths run from 2.5 mg up to 15 mg; each represents a fixed volume delivered by the pre-filled pen.
Dose changes are clinically assessed, if you are unsure what your prescribed dose looks like in any unit, your prescriber or pharmacist is the right person to ask.

Tirzepatide doses are measured in milligrams (mg), but the pens that deliver those doses are marked in units. Converting between the two is straightforward once you know the concentration, and the short answer is that each Mounjaro KwikPen contains 4 mg per ml — so a 2.5 mg dose equals 0.625 ml, a 5 mg dose equals 1.25 ml, and so on. That said, you will never need to draw up a syringe or calculate these figures yourself: the KwikPen delivers each pre-set dose automatically, so the conversion is purely for understanding. Mounjaro is a prescription-only medicine, and every dose change is a clinical decision made by your prescriber, not something to adjust based on a unit count.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

Understanding the numbers behind your tirzepatide prescription

Why do people convert tirzepatide mg to units in the first place?

A question our prescribers hear most weeks goes something like: "My pen says 2.5 mg, how many units is that?" It usually comes from people who have experience with insulin, which is always measured in international units, or from those who have read forum discussions where doses are described in millilitres or units rather than milligrams.

Tirzepatide is not dosed in international units at all. The milligrams printed on the box and the pen barrel are the only official measurement. The word "units" in this context is informal shorthand for the volume the pen delivers, not a separate measurement system. So when you see a guide converting 2.5 mg of tirzepatide into units, what it is really doing is expressing the dose as a volume of liquid, useful background knowledge, but nothing you act on.

The KwikPen is pre-set at the factory. You dial to the correct dose window, attach a needle, and inject. The pen stops automatically when the right volume has been delivered. There is no calculation involved for the patient.

What is the actual mg-to-unit conversion for tirzepatide?

Every Mounjaro KwikPen is formulated at a concentration of 4 mg per ml. That single fact is what you need for any tirzepatide units-to-mg conversion. Applying it across the six licensed UK strengths gives the following volumes:

The 2.5 mg starting dose delivers 0.625 ml. The 5 mg dose delivers 1.25 ml. At 7.5 mg the volume is 1.875 ml; at 10 mg it rises to 2.5 ml; at 12.5 mg to 3.125 ml; and the highest licensed dose, 15 mg, delivers 3.75 ml. If anyone refers to "units" loosely in conversation, they are almost always describing one of these volumes expressed differently, the underlying mg figure is what your prescription states and what matters clinically.

For a close look at how the 10 mg dose translates to a volume, or if you have been prescribed 40 units and want to work backwards to milligrams, the detail on converting 40 units back to mg walks through the same formula from the other direction.

The BNF's tirzepatide entry confirms the licensed strengths and concentration, and is the professional reference your prescriber works from.

Does the conversion change with each strength, or is the ratio fixed?

The ratio is fixed. Because all six Mounjaro pen strengths use the same 4 mg/ml concentration, the mg-to-volume relationship scales cleanly. Doubling the dose doubles the volume; halving it halves the volume. This consistency is intentional, it means that moving from, say, 5 mg to a higher dose involves no new calculation for a clinician working out what the pen will deliver.

What does change between the pens is the total fill volume and, in some cases, the number of doses per pen. Each pen contains four weekly doses at the labelled strength. A 2.5 mg pen and a 15 mg pen both provide four injections; the 15 mg pen simply contains more liquid in total. This is worth knowing if you are reading storage or travel guidance, because the pen you carry is physically the same format regardless of dose.

The NHS medicines page for tirzepatide is a reliable plain-language reference for understanding what your pen contains and how it works, separate from any commercial or clinical source.

When would you actually need this information?

Practically speaking, patients rarely need to translate tirzepatide mg to units themselves. The situations where it comes up are specific: travelling internationally and carrying documentation that lists volumes; speaking with a nurse or healthcare professional who uses a different shorthand; or simply wanting to understand what you are injecting.

If you are on a tirzepatide treatment plan and wondering what your current dose means in volume terms, it is worth keeping a copy of your Patient Information Leaflet, it documents the pen mechanics clearly. For anything that touches on changing your dose or timing, that conversation belongs with your prescriber. Titration decisions are not something to work out from a conversion table.

If you are still at the stage of exploring whether Mounjaro might be suitable for you, our free consultation is reviewed the same day by a GPhC-registered prescriber. For broader context on how tirzepatide fits into a weight-management plan, the weight loss treatments overview sets out the options clearly.

For full details on the cost of private tirzepatide treatment, the Mounjaro pricing page covers what a private prescription typically includes and what to look for when comparing providers.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions